Journal of Clinical Medicine (Jul 2022)

Effectiveness of a Multifaced Antibiotic Stewardship Program: A Pre-Post Study in Seven Italian ICUs

  • Giulia Mandelli,
  • Francesca Dore,
  • Martin Langer,
  • Elena Garbero,
  • Laura Alagna,
  • Andrea Bianchin,
  • Rita Ciceri,
  • Antonello Di Paolo,
  • Tommaso Giani,
  • Aimone Giugni,
  • Andrea Gori,
  • Ugo Lefons,
  • Antonio Muscatello,
  • Carlo Olivieri,
  • Angelo Pan,
  • Matteo Pedeferri,
  • Marianna Rossi,
  • Gian Maria Rossolini,
  • Emanuele Russo,
  • Daniela Silengo,
  • Bruno Viaggi,
  • Guido Bertolini,
  • Stefano Finazzi

DOI
https://doi.org/10.3390/jcm11154409
Journal volume & issue
Vol. 11, no. 15
p. 4409

Abstract

Read online

Multidrug resistance has become a serious threat for health, particularly in hospital-acquired infections. To improve patients’ safety and outcomes while maintaining the efficacy of antimicrobials, complex interventions are needed involving infection control and appropriate pharmacological treatments in antibiotic stewardship programs. We conducted a multicenter pre-post study to assess the impact of a stewardship program in seven Italian intensive care units (ICUs). Each ICU was visited by a multidisciplinary team involving clinicians, microbiologists, pharmacologists, infectious disease specialists, and data scientists. Interventions were targeted according to the characteristics of each unit. The effect of the program was measured with a panel of indicators computed with data from the MargheritaTre electronic health record. The median duration of empirical therapy decreased from 5.6 to 4.6 days and the use of quinolones dropped from 15.3% to 6%, both p < 0.001. The proportion of multi-drug-resistant bacteria (MDR) in ICU-acquired infections fell from 57.7% to 48.8%. ICU mortality and length of stay remained unchanged, indicating that reducing antibiotic administration did not harm patients’ safety. This study shows that our stewardship program successfully improved the management of infections. This suggests that policy makers should tackle multidrug resistance with a multidisciplinary approach based on continuous monitoring and personalised interventions.

Keywords